Cargando…
A case report of breast cancer and membranous nephropathy with positive anti phospholipase A2 receptor antibodies
BACKGROUND: Testing for antibodies against podocyte phospholipase A2 receptor-1 (PLA2R) allows clinicians to accurately identify primary membranous nephropathy (MN). Secondary MN is associated with a spectrum of pathology including solid organ malignancy. PLA2R positivity in these patients occurs, a...
Autores principales: | Mathew, David, Gupta, Sanjana, Ashman, Neil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482676/ https://www.ncbi.nlm.nih.gov/pubmed/34592934 http://dx.doi.org/10.1186/s12882-021-02511-x |
Ejemplares similares
-
Anti-phospholipase A2 receptor antibodies in membranous nephropathy
por: Lee, Sangho
Publicado: (2018) -
Coexistence of ANCA-associated glomerulonephritis and anti-phospholipase A(2) receptor antibody-positive membranous nephropathy
por: Surindran, Sheena, et al.
Publicado: (2012) -
Primary antiphospholipid syndrome associated with anti-phospholipase A2 receptor antibody-positive membranous nephropathy
por: Teisseyre, Maxime, et al.
Publicado: (2020) -
Anti-phospholipase A2 receptor antibody and spontaneous remission in membranous nephropathy
por: Diaz, Montserrat, et al.
Publicado: (2018) -
Anti-phospholipase A2 Receptor Antibody-Negative Membranous Nephropathy in Pregnancy
por: Saleem, Maryam, et al.
Publicado: (2023)